HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erik F J de Vries Selected Research

Turpentine

1/2008Evaluation of [(11)C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation.
4/2004Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erik F J de Vries Research Topics

Disease

27Neoplasms (Cancer)
11/2022 - 01/2002
23Neuroinflammatory Diseases
02/2024 - 09/2006
19Breast Neoplasms (Breast Cancer)
02/2024 - 02/2012
14Inflammation (Inflammations)
02/2024 - 10/2003
7Multiple Sclerosis
01/2022 - 01/2008
4Parkinson Disease (Parkinson's Disease)
02/2024 - 01/2008
4Anhedonia
03/2023 - 06/2020
4Neoplasm Metastasis (Metastasis)
11/2022 - 10/2013
4Brain Neoplasms (Brain Tumor)
01/2022 - 01/2020
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2008
4Disease Progression
01/2017 - 09/2006
4Herpes Simplex Encephalitis (Herpes Encephalitis)
05/2016 - 11/2009
4Demyelinating Diseases (Demyelinating Disease)
10/2014 - 02/2014
3Schizophrenia (Dementia Praecox)
11/2023 - 10/2022
3Cognitive Dysfunction
01/2020 - 03/2010
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2019 - 08/2014
3Glioma (Gliomas)
01/2018 - 04/2004
3Carcinoma (Carcinomatosis)
04/2017 - 01/2005
3Alzheimer Disease (Alzheimer's Disease)
03/2014 - 10/2003
2Mental Disorders (Mental Disorder)
01/2024 - 06/2015
2Infections
11/2023 - 01/2016
2Neurobehavioral Manifestations
11/2023 - 01/2022
2Psychotic Disorders (Schizoaffective Disorder)
07/2023 - 01/2020
2Body Weight (Weight, Body)
01/2023 - 01/2020
2Melanoma (Melanoma, Malignant)
01/2022 - 12/2021
2Brain Diseases (Brain Disorder)
05/2019 - 03/2014
2Ischemia
01/2019 - 10/2003
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 07/2004
1Wounds and Injuries (Trauma)
07/2023
1Memory Disorders (Memory Loss)
10/2022
1Weight Gain
01/2022
1Central Nervous System Diseases (CNS Diseases)
01/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2021

Drug/Important Bio-Agent (IBA)

13Estrogen ReceptorsIBA
01/2024 - 02/2012
8Proteins (Proteins, Gene)FDA Link
11/2023 - 01/2005
816-fluoroestradiolIBA
01/2023 - 01/2018
7Glucose (Dextrose)FDA LinkGeneric
10/2022 - 09/2006
7PK 11195 (PK11195)IBA
08/2016 - 01/2008
6Biomarkers (Surrogate Marker)IBA
02/2024 - 09/2006
6Estradiol (Delestrogen)FDA LinkGeneric
11/2022 - 10/2015
6EnzymesIBA
11/2021 - 05/2010
5GlucuronidaseIBA
11/2012 - 05/2010
5ProdrugsIBA
11/2012 - 01/2002
4(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA
11/2023 - 01/2017
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2024 - 04/2004
3LigandsIBA
11/2023 - 01/2008
3Antipsychotic Agents (Antipsychotics)IBA
07/2023 - 10/2014
3Sucrose (Saccharose)IBA
03/2023 - 01/2022
3N-methyl-4,4'-diaminostilbeneIBA
01/2022 - 02/2014
3Interleukin-2 Receptors (IL 2 Receptor)IBA
12/2021 - 10/2010
3RadiopharmaceuticalsIBA
01/2021 - 10/2010
3Androgen Receptors (Androgen Receptor)IBA
01/2021 - 12/2017
3Estrogens (Estrogen)FDA Link
04/2017 - 03/2014
3Cytostatic AgentsIBA
11/2012 - 03/2010
3GABA-A Receptors (GABA(A) Receptor)IBA
11/2009 - 09/2006
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2008 - 10/2003
2Cholinergic Agents (Cholinergics)IBA
02/2024 - 01/2020
2RacloprideIBA
02/2024 - 01/2020
2CytokinesIBA
11/2023 - 01/2012
2Antiviral Agents (Antivirals)IBA
11/2023 - 09/2006
2CorticosteroneIBA
03/2023 - 01/2022
2Immune Checkpoint InhibitorsIBA
01/2022 - 12/2021
2Interleukin-2 (IL2)IBA
12/2021 - 10/2012
2Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2020 - 05/2019
2isoquinolineIBA
01/2020 - 11/2009
2Deoxyglucose (2 Deoxy D glucose)IBA
01/2020 - 02/2012
2Myelin-Oligodendrocyte GlycoproteinIBA
10/2019 - 08/2014
22- fluoro- 6- (6- hydroxynaphthalen- 2- yl)pyridin- 3- olIBA
11/2017 - 04/2017
2GenisteinIBA
11/2017 - 04/2017
2Hormones (Hormone)IBA
10/2015 - 03/2014
2Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
10/2014 - 05/2014
2Insulin (Novolin)FDA Link
12/2012 - 11/2012
2TurpentineIBA
01/2008 - 04/2004
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
02/2024
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
02/2024
1Dopamine Receptors (Dopamine Receptor)IBA
02/2024
1istradefyllineIBA
02/2024
1Interleukin-10 (Interleukin 10)IBA
11/2023
1Indicators and Reagents (Reagents)IBA
11/2023
1Valacyclovir (Valtrex)FDA LinkGeneric
11/2023
1Poly I-CIBA
11/2023
1SynaptophysinIBA
11/2023
1Silver Sulfadiazine (SSD)FDA LinkGeneric
07/2023
1Simvastatin (Zocor)FDA LinkGeneric
07/2023
1Histamine AgonistsIBA
01/2022
1Antidepressive Agents (Antidepressants)IBA
01/2022
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
01/2022
1KetamineFDA LinkGeneric
01/2022
16- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA
01/2022
1Cyclooxygenase 1IBA
11/2021
1Dihydrotestosterone (Androstanolone)IBA
01/2021
1enzalutamideIBA
01/2021
1bicalutamide (Casodex)FDA LinkGeneric
01/2021
1AZD 6244IBA
12/2020
1BMS-986192IBA
12/2020
1elacestrantIBA
10/2020

Therapy/Procedure

17Therapeutics
01/2022 - 01/2008
3Immunotherapy
05/2022 - 12/2012
3Radiotherapy
01/2020 - 01/2018
2Drug Therapy (Chemotherapy)
10/2014 - 11/2012